Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 209
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Quarterly Psychedelics Briefing: Q3 2026
Weekly Psychedelic Policy Briefing, September 21, 2026
Health Canada Authorizes Optimi’s Natural Psilocybin Trial as House Bill Targets Botanical Drug Exclusivity
Pα+ Psychedelic Bulletin #232: Q2’26 Psychedelic Lobbying Update; DEA Again Moves to Schedule 5 Tryptamines; Oregon Backpedals Psilocybin Fee Hike
Podcast: Psychedelics in D.C., FDA’s Framework, and New Zealand’s MDMA Prescribers
Mydecine Submits Pre-Investigational New Drug Briefing Package to the FDA for...
Psychedelic or Not: Of Mice, 5-HT2A Agonists, and Head Shakes
PT289 – Payton Nyquvest – Shifting the Mindset on Pain, Psychedelics,...
Psychedelic Bulletin: MDMA Fast-Tracked in UK; FDA Clears MindMed LSD Trial;...
Red Light Holland’s Partner CCrest Laboratories Approved By Health Canada to...
PT288 – Annie & Michael Mithoefer – Vital Psychedelic Conversations
Numinus Identified as a Licensed Psilocybin Supplier by Health Canada
MDMA-Assisted Psychotherapy for PTSD: Interviewing Dr. Rachel Yehuda
Nova Mentis and KGK Science Form Tactical Partnership
Numinus Wellness Inc. Graduates to the OTCQX Best Market
Load more